| Stem definition | Drug id | CAS RN |
|---|---|---|
| antihistaminics | 249 | 68844-77-9 |
| Dose | Unit | Route |
|---|---|---|
| 10 | mg | O |
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
| EoM (Fraction excreted unchanged in urine) | 0.50 % | Benet LZ, Broccatelli F, Oprea TI |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.36 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BA (Bioavailability) | 2 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Dec. 31, 1988 | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | R06AX11 | RESPIRATORY SYSTEM ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE Other antihistamines for systemic use |
| CHEBI has role | CHEBI:37955 | H1 receptor antagonists |
| CHEBI has role | CHEBI:50857 | anti-allergic drugs |
| CHEBI has role | CHEBI:149553 | anticoronaviral drug |
| MeSH PA | D018926 | Anti-Allergic Agents |
| MeSH PA | D018494 | Histamine Agents |
| MeSH PA | D006633 | Histamine Antagonists |
| MeSH PA | D006634 | Histamine H1 Antagonists |
| MeSH PA | D039563 | Histamine H1 Antagonists, Non-Sedating |
| MeSH PA | D018377 | Neurotransmitter Agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Allergic rhinitis | indication | 61582004 | |
| Sneezing | indication | 76067001 | |
| Chronic idiopathic urticaria | indication | 302162004 | |
| Allergic conjunctivitis | indication | 473460002 | DOID:11204 |
| Urticaria | off-label use | 126485001 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.47 | Basic |
| pKa2 | 5.81 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Histamine H1 receptor | GPCR | ANTAGONIST | A2 | 8.58 | WOMBAT-PK | SCIENTIFIC LITERATURE | |||
| Beta-1 adrenergic receptor | GPCR | Ki | 5.00 | DRUG MATRIX | |||||
| Mu-type opioid receptor | GPCR | Ki | 6.22 | DRUG MATRIX | |||||
| D(1A) dopamine receptor | GPCR | Ki | 5.70 | DRUG MATRIX | |||||
| D(2) dopamine receptor | GPCR | Ki | 5.82 | DRUG MATRIX | |||||
| Alpha-2A adrenergic receptor | GPCR | Ki | 5.74 | DRUG MATRIX | |||||
| Sigma non-opioid intracellular receptor 1 | Membrane receptor | Ki | 6.03 | DRUG MATRIX | |||||
| Potassium voltage-gated channel subfamily H member 2 | Ion channel | IC50 | 9.05 | WOMBAT-PK | |||||
| Cytochrome P450 3A4 | Enzyme | IC50 | 5.48 | WOMBAT-PK | |||||
| Multidrug resistance protein 1 | Transporter | IC50 | 6.05 | WOMBAT-PK | |||||
| Sodium-dependent serotonin transporter | Transporter | Ki | 6.16 | DRUG MATRIX | |||||
| Sodium-dependent noradrenaline transporter | Transporter | Ki | 5.87 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 1A | GPCR | Ki | 6.36 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2A | GPCR | Ki | 8.25 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2B | GPCR | Ki | 8.13 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 7.03 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 6 | GPCR | Ki | 5.82 | DRUG MATRIX | |||||
| Alpha-2B adrenergic receptor | GPCR | Ki | 5.76 | DRUG MATRIX | |||||
| D(3) dopamine receptor | GPCR | Ki | 6.83 | DRUG MATRIX | |||||
| Histamine H2 receptor | GPCR | Ki | 5.78 | DRUG MATRIX | |||||
| Histamine H4 receptor | GPCR | Ki | 5.10 | CHEMBL | |||||
| Muscarinic acetylcholine receptor M1 | GPCR | Ki | 6.59 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M2 | GPCR | Ki | 6.30 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M3 | GPCR | Ki | 6.75 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M4 | GPCR | Ki | 6.59 | DRUG MATRIX | |||||
| Muscarinic acetylcholine receptor M5 | GPCR | Ki | 6.30 | DRUG MATRIX | |||||
| Beta-3 adrenergic receptor | GPCR | Ki | 5.22 | DRUG MATRIX | |||||
| Alpha-2C adrenergic receptor | GPCR | Ki | 6.55 | DRUG MATRIX | |||||
| Sodium-dependent dopamine transporter | Transporter | Ki | 6.10 | DRUG MATRIX | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.78 | DRUG MATRIX | |||||
| D(4) dopamine receptor | GPCR | Ki | 5.67 | DRUG MATRIX | |||||
| Alpha-1D adrenergic receptor | GPCR | Ki | 8.00 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 3A | Ion channel | Ki | 7.02 | DRUG MATRIX | |||||
| Kappa-type opioid receptor | GPCR | Ki | 5.58 | DRUG MATRIX | |||||
| ATP-binding cassette sub-family G member 2 | Transporter | WOMBAT-PK | |||||||
| Glycine receptor subunit alpha-1 | Ion channel | EC50 | 5.38 | CHEMBL | |||||
| Calmodulin | Cytosolic other | IC50 | 6 | WOMBAT-PK | |||||
| Delta-type opioid receptor | GPCR | Ki | 5.34 | DRUG MATRIX | |||||
| Somatostatin receptor type 5 | GPCR | Ki | 5.39 | CHEMBL | |||||
| Epidermal growth factor receptor | Kinase | IC50 | 5.22 | DRUG MATRIX | |||||
| Substance-P receptor | GPCR | Ki | 5.07 | DRUG MATRIX | |||||
| Tyrosine-protein kinase Lck | Kinase | IC50 | 4.70 | DRUG MATRIX | |||||
| Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.55 | DRUG MATRIX | |||||
| Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 4.88 | DRUG MATRIX | |||||
| Substance-K receptor | GPCR | Ki | 6.00 | DRUG MATRIX | |||||
| Potassium voltage-gated channel subfamily H member 1 | Ion channel | BLOCKER | IC50 | 6.70 | IUPHAR | ||||
| Melanocortin receptor 4 | GPCR | Ki | 4.87 | DRUG MATRIX | |||||
| Melanocortin receptor 5 | GPCR | Ki | 5.67 | DRUG MATRIX | |||||
| Melanocortin receptor 3 | GPCR | Ki | 4.87 | DRUG MATRIX | |||||
| Sodium/nucleoside cotransporter 1 | Transporter | Ki | 5.31 | DRUG MATRIX | |||||
| Multidrug and toxin extrusion protein 1 | Transporter | IC50 | 4.58 | CHEMBL | |||||
| Polycomb protein EED | Unclassified | IC50 | 4.03 | CHEMBL | |||||
| HLA class I histocompatibility antigen, A-3 alpha chain | Unclassified | Kd | 5.60 | CHEMBL | |||||
| Transmembrane protein 97 | Enzyme | Ki | 7.02 | CHEMBL | |||||
| Nuclear receptor subfamily 4 group A member 2 | Nuclear other | Kd | 4 | CHEMBL | |||||
| Alpha-1B adrenergic receptor | GPCR | Ki | 7.02 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 1B | GPCR | Ki | 6.20 | DRUG MATRIX | |||||
| Membrane-associated progesterone receptor component 1 | Membrane receptor | Ki | 6.73 | DRUG MATRIX | |||||
| Alpha-1A adrenergic receptor | GPCR | IC50 | 7.62 | CHEMBL | |||||
| Protein farnesyltransferase | Enzyme | IC50 | 8.70 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 1A | GPCR | IC50 | 6.12 | CHEMBL |
| ID | Source |
|---|---|
| 4019379 | VUID |
| N0000147536 | NUI |
| D00234 | KEGG_DRUG |
| 202818 | RXNORM |
| C0085170 | UMLSCUI |
| CHEBI:2896 | CHEBI |
| XB7 | PDB_CHEM_ID |
| CHEMBL296419 | ChEMBL_ID |
| CHEMBL61301 | ChEMBL_ID |
| D016589 | MESH_DESCRIPTOR_UI |
| DB00637 | DRUGBANK_ID |
| 2603 | IUPHAR_LIGAND_ID |
| 4755 | INN_ID |
| 7HU6337315 | UNII |
| 2247 | PUBCHEM_CID |
| 4224 | MMSL |
| 768 | MMSL |
| d00794 | MMSL |
| 387333002 | SNOMEDCT_US |
| 59456005 | SNOMEDCT_US |
| 4019379 | VANDF |
| 003413 | NDDF |
None